학술논문

Entrectinib demonstrates prolonged efficacy in an adult case of radiation-refractory NTRK fusion glioblastoma
Document Type
Article
Source
In: Neuro-Oncology Advances. (Neuro-Oncology Advances, 1 January 2022, 4(1))
Subject
Language
English
ISSN
26322498